MARKET

BSX

BSX

Boston Scient
NYSE

Real-time Quotes | Nasdaq Last Sale

41.61
+0.26
+0.63%
After Hours: 41.85 +0.24 +0.56% 17:44 05/13 EDT
OPEN
41.51
PREV CLOSE
41.35
HIGH
41.88
LOW
41.33
VOLUME
5.01M
TURNOVER
--
52 WEEK HIGH
44.63
52 WEEK LOW
32.99
MARKET CAP
59.12B
P/E (TTM)
298.71
1D
5D
1M
3M
1Y
5Y
BRIEF-Boston Scientific Corp Says On May 10, Entered Into $2.750 Billion Revolving Credit Agreement
reuters.com · 8h ago
Westpac Banking Corp Buys Eli Lilly and Co, Bank of America Corp, American Tower Corp, Sells ...
GuruFocus News · 17h ago
Is Now The Time To Look At Buying Boston Scientific Corporation (NYSE:BSX)?
Boston Scientific Corporation ( NYSE:BSX ) saw a decent share price growth in the teens level on the NYSE over the last...
Simply Wall St. · 23h ago
Global Prostatic Arterial Embolization Market: By Analyzing the Performance of Various Competitors 2027 | Merit Medical Systems (MMSI), Boston Scientific (BSX), Mentice (MN2), Siemens Healthineers (SHL)
May 12, 2021 (AmericaNewsHour) -- Research Nester released a report titled "Prostatic Arterial Embolization Market: Global Demand Analysis & Opportunity...
AmericaNewsHour · 1d ago
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
Investor confidence is high on the DaVita (DVA) stock, courtesy of its solid prospects.
Zacks · 1d ago
Global & USA Angiographic Catheter Market Size, Share, Value, And Competitive Landscape 2021 - 2026
May 12, 2021 (Heraldkeepers) -- In this report, HeyReport discusses the Global & USA industrial policies, economic environment, and the impact of...
Heraldkeepers · 1d ago
Competitive Scenario of Y-Connector Hemostasis Valves Market Growth, Size, Demand, Forecast with Depth Assessment by Top Key Players 2026
May 12, 2021 (The Expresswire) -- Global "Y-Connector Hemostasis Valves Market"(2021-2026) provides an all-inclusive assessment of the market and offers a...
The Express Wire · 1d ago
Global Transcutaneous Electrical Nerve Stimulators Market Size by Production, Top Countries Import-Export and Consumption Forecast & Regional Analysis by 2026
May 12, 2021 (The Expresswire) -- Global "Transcutaneous Electrical Nerve Stimulators Market"(2021-2026) provides an all-inclusive assessment of the market...
The Express Wire · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BSX. Analyze the recent business situations of Boston Scient through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 28 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BSX stock price target is 49.04 with a high estimate of 52.00 and a low estimate of 41.00.
EPS
Institutional Holdings
Institutions: 1.15K
Institutional Holdings: 1.40B
% Owned: 98.36%
Shares Outstanding: 1.42B
TypeInstitutionsShares
Increased
326
142.22M
New
120
17.02M
Decreased
281
167.02M
Sold Out
97
28.43M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.54%
Healthcare Equipment & Supplies
+0.54%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Mahoney
Chief Financial Officer/Executive Vice President
Daniel Brennan
Executive Vice President
Arthur Butcher
Executive Vice President
Joseph Fitzgerald
Executive Vice President
Edward Mackey
Executive Vice President
Ian Meredith
Executive Vice President
Jeffrey Mirviss
Executive Vice President
David Pierce
Executive Vice President
Eric Thepaut
Senior Vice President/Chief Information Officer
Jodi Eddy
Senior Vice President/General Counsel/Secretary
Desiree Ralls-Morrison
Senior Vice President/General Counsel/Secretary
Desiree Rallsmorrison
Senior Vice President/Director of Human Resources
Wendy Carruthers
Senior Vice President
Maulik Nanavaty
Senior Vice President
Scott Olson
Senior Vice President
Meghan Scanlon
Senior Vice President
John Sorenson
Lead Director/Independent Director
Edward Ludwig
Independent Director
Nelda Connors
Independent Director
Charles Dockendorff
Independent Director
Yoshiaki Fujimori
Independent Director
Donna James
Independent Director
Stephen MacMillan
Independent Director
David Roux
Independent Director
John Sununu
Independent Director
Ellen Zane
No Data
  • All
  • Financials
  • Insiders
More
About BSX
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BSX stock methods without spending real money on the virtual paper trading platform.